JFG
IMUX icon

Jefferies Financial Group’s Immunic IMUX Stock Holding History

Jefferies Financial Group’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,280
Closed -$59.9K – 1784
2022
Q4 		$59.9K Buy
+4,280
New +$117K ﹤0.01% 1403

Other funds holding IMUX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Jefferies Financial Group's IMUX Position: Q2 2026 in Review

Jefferies Financial Group opened a new position in Immunic (IMUX) in Q2 2026: 84,900 shares worth $1.3M. The stake represents 0.01% of the portfolio and ranks #854 among its holdings. This is a return to the name: Jefferies Financial Group previously reported a position in IMUX as recently as Q2 2024.

Jefferies Financial Group first reported a position in IMUX in Q4 2022 and has held it in 3 quarters since. 56 funds tracked by Wall St. Rank hold IMUX as of Q2 2026.

  • Jefferies Financial Group held 84,900 shares of Immunic worth $1.3M as of Q2 2026.
  • Immunic was a new Jefferies Financial Group position in Q2 2026.
  • Immunic made up 0.01% of Jefferies Financial Group's portfolio in Q2 2026, its #854 holding.
  • Jefferies Financial Group first reported a position in Immunic in Q4 2022 and has held it in 3 quarters since.
  • 56 funds tracked by Wall St. Rank held Immunic as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.